Participated · Seed · Mar 2025

Covision Media develops AI-based 3D scanning hardware and software to mass-produce reality-grade 3D models for e-commerce, AR/VR, gaming, and industrial use. Founded in 2020 by Burkhard Güssefeld and Franz Tschimben and based in Bressanone, the company sells scanners and software that automate large-scale 3D content production. Customers named in the articles include adidas, Inditex Group (ZARA and Massimo Dutti), GUCCI, Salomon, Quad Graphics, NUREG, and CLX Europe. Its technology is used for virtual try-on, higher-quality in-game assets, marketing assets, and to help build large, high-quality 3D datasets for 3D machine learning—Meta is using Covision’s technology for a 3D Digital Twin Catalog. The company plans to commercialise its scanning technology globally and accelerate development of AI-powered products such as text-to-3D and image-to-3D tools. The recent seed funding will strengthen the core scanning business and enable automated, at-scale 3D content generation and further product development.

Participated · Series A · Mar 2025

XUND develops MDR-certified SaMD products and an internal large language model called RAVE to support digital interactions from prevention through diagnosis. Its solutions are already used by insurers, hospitals, and pharmaceutical companies as the first digital point of contact. The company employs more than 40 people across Vienna, Budapest, and London. Founded in 2018, XUND positions itself as a European homegrown champion in AI-powered healthcare infrastructure. With a recent €6 million pre-Series A raise, it is pursuing accelerated expansion in DACH and the UK and plans deeper integration of its medical devices with RAVE. The firm emphasizes building a data-driven, personalised healthcare system and aligning with EU initiatives around AI investment and technological sovereignty. XUND builds an AI-powered health assistant and four medical modules to digitise the entire patient lifecycle, enabling digital interactions from prevention to diagnosis and monitoring. Its platform uses proprietary NLP models that analyse millions of medical publications and is considered a class IIa medical device under the EU MDR. The company’s B2B customers include health insurers, healthcare providers, pharmaceutical companies, pharmacies and digital health firms. XUND plans to develop Medical Large Language Models (MedLLMs) in partnership with Thieme Group, using Thieme’s medical content combined with XUND’s NLP technology to deliver personalised medical content. The initial joint prototype with Thieme will be showcased at DMEA. XUND raised an additional €2M in a seed extension, bringing total funding to €8M to support product development and growth. XUND uses AI to analyse and process millions of medical publications and offers a medically approved/certified API that customers can use as a baseline for digital symptom assessment and patient navigation. The platform combines symptoms, personal risk factors, and demographic data to help users understand their symptoms, receive reliable assessments of possible causes, and take appropriate next steps. CEO and co-founder Tamás Petrovics says the company aims to cover the entire patient lifecycle from prevention through diagnosis, treatment, and monitoring. XUND positions itself as an infrastructure provider for digital patient interactions across insurance, pharma, digital and in-person healthcare. Financially, the company recently closed a €6 million seed round — described as one of Austria’s largest seed rounds to date. The new capital will be used to expand operations beyond the DACH region into additional European markets and to enter the U.S. market.

Participated · Seed · Jul 2024

Tree.ly develops forest climate protection projects across Austria, Germany and wider Europe, working with forest owners, municipalities, corporations and citizens. Its core offering combines geospatial engines with ML-powered stock measurement, species detection and stock-change modelling to design and monitor projects. Projects are third-party certified and annually audited by TÜV, and Tree.ly says its scientifically proven methodology is ISO-certified to ensure additionality, prevent leakage and manage permanence risks. In its first year the company secured contracts covering 105,299 hectares and storing over 2.8 million tons of CO₂. Tree.ly positions itself as a fast-growing technology company in voluntary carbon markets and plans to use new funding to accelerate growth in European markets, strengthen technological leadership, and develop new forest-based climate protection offerings. Founders named in the article are Jodok Batlogg and Christian-Lutz.